POST-STROKE HYPERGLYCAEMIA – TREATMENT WITH EXENATIDE IN ACUTE ISCHAEMIC STROKE (TEXAIS) TRIAL

Grant number: 1126070 | Funding period: 2017 - 2021

Active

Abstract

Raised blood glucose levels (hyperglycaemia) after a stroke is common. It reduces the efficacy of stroke treatments and results in worse outcomes. Insulin is not useful as a treatment for this as it causes frequent hypoglycaemia and does not improve clinical outcomes. Exenatide is a common diabetes drug that is simple to use and lowers blood glucose without hypoglycaemia. It will be tested in the Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial.

University of Melbourne Researchers